Found: 104
Select item for more details and to access through your institution.
Only Plasmapheresis Allows for Danaparoid Elimination from Blood.
- Published in:
- Kidney & Blood Pressure Research, 2004, v. 27, n. 5/6, p. 360
- By:
- Publication type:
- Article
Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Positive Association Between Adipose Tissue and Bone Stiffness.
- Published in:
- Calcified Tissue International, 2015, v. 97, n. 1, p. 40, doi. 10.1007/s00223-015-0008-3
- By:
- Publication type:
- Article
The enteroinsular axis may mediate the diabetogenic effects of TCF7L2 polymorphisms.
- Published in:
- Diabetologia, 2007, v. 50, n. 12, p. 2413, doi. 10.1007/s00125-007-0832-8
- By:
- Publication type:
- Article
Response to comment on: Nauck MA, Duran S, Kim D et al (2007) A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia 50:259–267
- Published in:
- 2007
- By:
- Publication type:
- Letter
Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects.
- Published in:
- Diabetologia, 2007, v. 50, n. 4, p. 806, doi. 10.1007/s00125-007-0598-z
- By:
- Publication type:
- Article
A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study.
- Published in:
- Diabetologia, 2007, v. 50, n. 2, p. 259, doi. 10.1007/s00125-006-0510-2
- By:
- Publication type:
- Article
Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans.
- Published in:
- Diabetologia, 2006, v. 49, n. 3, p. 452, doi. 10.1007/s00125-005-0126-y
- By:
- Publication type:
- Article
Comment to: Patti ME, Mcmahon G, Mun EC et al. (2005) Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 48:2236–2240.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.
- Published in:
- Diabetologia, 2005, v. 48, n. 9, p. 1872, doi. 10.1007/s00125-005-1863-7
- By:
- Publication type:
- Article
The therapeutic actions of DPP-IV inhibition are not mediated by glucagon-like peptide-1.
- Published in:
- Diabetologia, 2005, v. 48, n. 4, p. 608, doi. 10.1007/s00125-005-1704-8
- By:
- Publication type:
- Article
Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia J.J. Meier et al.: GIP and glucagon secretion.
- Published in:
- Diabetologia, 2003, v. 46, n. 6, p. 798, doi. 10.1007/s00125-003-1103-y
- By:
- Publication type:
- Article
Cloning and quantitative determination of the human Ca<sup>2+</sup>/calmodulin-dependent protein kinase II (CaMK II) isoforms in human beta cells.
- Published in:
- Diabetologia, 2000, v. 43, n. 4, p. 465, doi. 10.1007/s001250051330
- By:
- Publication type:
- Article
Development and External Validation of a Multivariable Prediction Model to Identify Nondiabetic Hyperglycemia and Undiagnosed Type 2 Diabetes: Diabetes Risk Assessment in Dentistry Score (DDS).
- Published in:
- Journal of Dental Research, 2023, v. 102, n. 2, p. 170, doi. 10.1177/00220345221129807
- By:
- Publication type:
- Article
Construction of a Biological Age Score to Predict Tooth Loss over 10 Years.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The Saliva Metabolome in Association to Oral Health Status.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Do Genetic Markers of Inflammation Modify the Relationship between Periodontitis and Nonalcoholic Fatty Liver Disease? Findings from the SHIP Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Prospective Study of Serum 25-hydroxy Vitamin D and Tooth Loss.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Effect of body shape and inflammation on tooth loss in men and women.
- Published in:
- Clinical Oral Investigations, 2017, v. 21, n. 1, p. 183, doi. 10.1007/s00784-016-1775-6
- By:
- Publication type:
- Article
Haplotypes of the cholesteryl ester transfer protein gene predict lipid-modifying response to statin therapy.
- Published in:
- Pharmacogenomics Journal, 2003, v. 3, n. 5, p. 284, doi. 10.1038/sj.tpj.6500195
- By:
- Publication type:
- Article
Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue.
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 12, p. 1163, doi. 10.1111/j.1463-1326.2009.01158.x
- By:
- Publication type:
- Article
Excess glycaemic excursions after an oral glucose tolerance test compared with a mixed meal challenge and self-measured home glucose profiles: is the OGTT a valid predictor of postprandial hyperglycaemia and vice versa?
- Published in:
- Diabetes, Obesity & Metabolism, 2009, v. 11, n. 3, p. 213, doi. 10.1111/j.1463-1326.2008.00922.x
- By:
- Publication type:
- Article
Glucose homeostasis and the gastrointestinal tract: insights into the treatment of diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2008, v. 10, n. 1, p. 18, doi. 10.1111/j.1463-1326.2007.00737.x
- By:
- Publication type:
- Article
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2007, v. 9, n. 2, p. 194, doi. 10.1111/j.1463-1326.2006.00704.x
- By:
- Publication type:
- Article
Age-specific reference ranges for serum testosterone and androstenedione concentrations in women measured by liquid chromatography-tandem mass spectrometry.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Do current incretin mimetics exploit the full therapeutic potential inherent in GLP-1 receptor stimulation?
- Published in:
- Diabetologia, 2013, v. 56, n. 9, p. 1878, doi. 10.1007/s00125-013-2953-6
- By:
- Publication type:
- Article
Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
- Published in:
- 2013
- By:
- Publication type:
- Correction Notice
Direct effect of GLP-1 infusion on endogenous glucose production in humans.
- Published in:
- Diabetologia, 2013, v. 56, n. 1, p. 156, doi. 10.1007/s00125-012-2738-3
- By:
- Publication type:
- Article
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
- Published in:
- Diabetologia, 2012, v. 55, n. 6, p. 1577, doi. 10.1007/s00125-012-2534-0
- By:
- Publication type:
- Article
Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?
- Published in:
- Diabetologia, 2011, v. 54, n. 1, p. 10, doi. 10.1007/s00125-010-1896-4
- By:
- Publication type:
- Article
Dualities of interest are not restricted to financial ties to the pharmaceutical industry.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Influence of gender, age, body mass index, abdominal fat and serum levels (HDL-C, glucose, triglycerides, IGF-1) on growth hormone (GH) response to GH-releasing hormone plus arginine and insulin tolerance tests.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Potassium - reference intervals for lithium-heparin plasma and serum from a population-based cohort.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Die Differentialdiagnostik von Fettstoffwechselstörungen unter besonderer Berücksichtigung methodischer Aspekte.
- Published in:
- Journal of Laboratory Medicine / Laboratoriums Medizin, 2001, v. 25, n. 1/2, p. 16
- By:
- Publication type:
- Article
Brief an den Herausgeber zum Schreiben von Dr. Klima zu Abstract P013 der Jahrestagung der Deutschen Gesellschaft für Klinische Chemie in Regensburg.
- Published in:
- Journal of Laboratory Medicine / Laboratoriums Medizin, 2000, v. 24, n. 6/7, p. 341
- By:
- Publication type:
- Article
Bestimmung von Lipoprotein(a): Vergleich eines neuen latexverstärkten immunoturbidimetrischen Assay mit einem immunoradiometrischen Assay.
- Published in:
- Journal of Laboratory Medicine / Laboratoriums Medizin, 1996, v. 20, n. 5, p. 294
- By:
- Publication type:
- Article
One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial.
- Published in:
- International Journal of Clinical Practice, 2011, v. 65, n. 4, p. 397, doi. 10.1111/j.1742-1241.2011.02656.x
- By:
- Publication type:
- Article
A case series of verrucae vulgares mimicking hyperkeratosis in individuals with diabetic foot ulcers.
- Published in:
- Diabetic Medicine, 2017, v. 34, n. 8, p. 1165, doi. 10.1111/dme.13387
- By:
- Publication type:
- Article
Polypharmacy in people with Type 1 and Type 2 diabetes is justified by current guidelines-a comprehensive assessment of drug prescriptions in patients needing inpatient treatment for diabetes-associated problems.
- Published in:
- Diabetic Medicine, 2014, v. 31, n. 9, p. 1078, doi. 10.1111/dme.12497
- By:
- Publication type:
- Article
Taspoglutide, a once-weekly glucagon-like peptide 1 analogue, vs. insulin glargine titrated to target in patients with Type 2 diabetes: an open-label randomized trial.
- Published in:
- Diabetic Medicine, 2013, v. 30, n. 1, p. 109, doi. 10.1111/dme.12003
- By:
- Publication type:
- Article
Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: a randomized double-blind placebo-controlled study [corrected] [published erratum appears in DIABETIC MED 2010 Jun;27(6):732].
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: a randomized double-blind placebo-controlled study.
- Published in:
- Diabetic Medicine, 2010, v. 27, n. 5, p. 556, doi. 10.1111/j.1464-5491.2010.02990.x
- By:
- Publication type:
- Article
α-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7–36 amide) and to delay gastric emptying in Type 2 diabetic patients.
- Published in:
- Diabetic Medicine, 2005, v. 22, n. 4, p. 470, doi. 10.1111/j.1464-5491.2005.01451.x
- By:
- Publication type:
- Article
Improvement in glycated haemoglobin evaluated by baseline body mass index: a meta-analysis of the liraglutide phase III clinical trial programme.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 7, p. 707, doi. 10.1111/dom.12617
- By:
- Publication type:
- Article
Impact of diabetes duration on achieved reductions in glycated haemoglobin, fasting plasma glucose and body weight with liraglutide treatment for up to 28 weeks: a meta-analysis of seven phase III trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 7, p. 721, doi. 10.1111/dom.12623
- By:
- Publication type:
- Article
Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 3, p. 203, doi. 10.1111/dom.12591
- By:
- Publication type:
- Article
Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo-controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 11, p. 1056, doi. 10.1111/dom.12539
- By:
- Publication type:
- Article
Safety and efficacy of once-weekly dulaglutide versus sitagliptin after 2 years in metformin-treated patients with type 2 diabetes ( AWARD-5): a randomized, phase III study.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 9, p. 849, doi. 10.1111/dom.12479
- By:
- Publication type:
- Article
Improved glucose control with reduced hypoglycaemic risk when linagliptin is added to basal insulin in elderly patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 9, p. 868, doi. 10.1111/dom.12490
- By:
- Publication type:
- Article
LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results ( LEADER) trial: preliminary observations.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 5, p. 477, doi. 10.1111/dom.12444
- By:
- Publication type:
- Article